1. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91:48–53. 2. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009; 92 (6): 1966–82. 3. Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod 2013; 28 (8): 2276–83. 4. Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Fertil Steril 2010; 93(1): 184–91. 5. Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (6): S65-112. 6. Gonzalez F, Sia CL, Stanczyk FZ, Blair HE, Krupa ME. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. Endocrine 2012; 42 (3): 726–35. 7. Maharaj A. Polycystic ovary syndrome. JEMDSA 2009; 14 (2): 86-95. 8. Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. J Obstet Gynaecol 2004; 24(6): 613–21. 9. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W. et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91(11): 4237–45. 10. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335(9): 617–23. 11. Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss III JF, Mcallister JM. Differential activity of the cytochrome P450 17 -hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 2000; 85(6): 2304–11. 12. Miri M, Jashni HK, Alipour F. Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS. J Ovarian Res 2014; 7: 37. 13. Mohan SK, Priya VV. 2009 Lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome. Biol Med 2009; 1 (3): 44-9. 14. Al-kataan MA, Ibrahim MA, Al-jammas MH, Shareef YS, Sulaiman MA. Serum Antioxidant Vitamins Changes in Women with Polycystic Ovarian Syndrome. J Bahrain Med Sci 2010; 22 (2): 68-71. 15. Amini L, Sadeghi Avvalshahr H. Complementary therapies in polycystic ovary syndrome. Darmangar 2011; 30: 48. [in Persian] 16. Dikmen A, Ergenoglu AM, Yeniel AO, Dilsiz OY, Ercan G, Yilmaz H. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats. Eur J Obstet Gynecol Reprod Biol 2012; 160(1): 55-9. 17. Wang S, He G, Chen M, Zuo T, Xu W, Liu X. The role of antioxidant enzymes in the ovaries. Oxid Med Cell Longev 2017; 2017: 4371714. 18. Moran LJ, Brinkworth G, Noakes M, Norman RJ. Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online 2006; 12(5): 569–78. 19. Yao Y, Wu M, Huang Y, Li C, Pan X, Zhu W, et al. Appropriately raising fermentation temperature beneficial to the increase of antioxidant activity and gallic acid content in Eurotium cristatum-fermented loose tea. LWT-Food Sci Technol 2017; 82: 248-54. 20. Mansouri MT, Farbood Y, Sameri MJ, Sarkaki A, Naghizadeh B, Rafeirad M. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food chem 2013; 138(2-3): 1028-33. 21. Karimi-Khouzani O, Heidarian E, Amini SA. Anti-inflammatory and ameliorative effects of gallic acid on fluoxetine-induced oxidative stress and liver damage in rats. Pharmacol Rep 2017; 69(4): 830-835. 22. Bruner B, Chad K, Chizen D. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab 2006; 31(4): 384–91. 23. Dikmen A, Ergenoglu AM, Yeniel AO, Dilsiz OY, Ercan G, Yilmaz H. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats. Eur J Obstet Gynecol Reprod Biol 2012; 160(1): 55-9. 24. Wu C, Lin F, Qiu S, Jiang Z. The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention. PLoS One 2014; 9(6): e99155. 25. Rafiei S, Bazyar Y, Edalatmanesh M A. Effect of gallic acid and endurance exercise training on BDNF in a model of hippocampal degeneration. Shefaye Khatam 2016; 4(1): 1-6. [in Persian] 26. Malek-Mohammadi R, Roghani M, Salami M. The effect of aqueous extracts of Melissa officinalis on the oxidative stress indices in the midbrain tissue. Feyz 2015; 19(1): 8-14. [in Persian] 27. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 2015; 36(5): 487–525. 28. Hosseinkhani A, Asadi N, Pasalar M, Mohammad MZ. Insights of traditional Persian medicine to polycystic ovary syndrome and its management. Planta Medica Int Open 2017; 4(S 01): Tu-PO. 29. Tomatis V, Wassell S, Venables M, Walker C, Ray S, Siervo M, et al. Effects of green tea and coffee polyphenols on cardiometabolic function in women with polycystic ovary syndrome. FASEB J 2015; 29(1 Supplement): LB271. 30. Rezvanfar MA, Shojaei Saadi HA, Gooshe M, Abdolghaffari AH, Baeeri M, Abdollahi M. Ovarian aging-like phenotype in the hyperandrogenism-induced murine model of polycystic ovary. Oxid Med Cell Longev 2014; 2014: 948951. 31. Roidoung S, Dolan KD, Siddiq M. Gallic acid as a protective antioxidant against anthocyanin degradation and color loss in vitamin-C fortified cranberry juice. Food Chem 2016; 210: 422-7. 32. Reckziegel P, Dias VT, Benvegnú DM, Boufleur N, Barcelos RC , Segat HJ, et al. Antioxident protection of gallic acid against toxicity induced by Pb in blood, liver and kidney of rats. Toxicol Reports 2016; 3: 351-6. 33. De Cristo Soares Alves A, Mainardes RM, Khalil NM. Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxidant activity. Mater Sci Eng C Mater Biol Appl 2016; 60:126-34. 34. Pal C, Bindu S, Dey S, Alam A, Goyal M, Iqbal MS, et al. Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis. Free Radic Biol Med 2010; 49(2): 258-67. 35. Priscilla DH, Prince PS. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chemico-Biological Interactions 2009; 179(2-3): 118-24. 36. Baziyar Y, Edalatmanesh MA, Hosseini SA, Zar A. The effects of endurance training and gallic acid on BDNF and TNF-A in male rats with Alzheimer. Int J Applied Exercise Physiol 2016; 5(4): 45-54. 37. Murri M, Luque-Ramırez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013; 19 (3): 268-88. 38. Benrick A, Maliqueo M, Miao S, Villanueva JA, Feng Y, Ohlsson C, et al. Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome. Evid Based Complement Alternat Med 2013; 2013: 964070. 39. Rafiei S, Edalatmanesh M A. The effect of exercise training on serum level of β-Estradiol, testosterone, and cognitive deficit in rats with letrozole-induced polycystic ovary syndrome. Shefaye Khatam 2016; 4(2): 11-8. [in Persian] 40. Al-Nozha O, Habib F, Mojaddidi M, El-Bab MF. Body weight reduction and metformin: Roles in polycystic ovary syndrome. Pathophysiology 2013; 20(2): 131-7. 41. Qiu S, Wu C, Lin F, Chen L, Huang Z, Jiang Z. Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome. Horm Metab Res 2009; 41(12): 880-5.
|